Notice Title

Consent to the Distribution of New Medicines

Publication Date
3 Jul 2025

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2025-go3537
Title
View PDF
File Type and Size
PDF (26 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule

Product: Advil Children 7-12 Years Pain & Fever Relief (Pharmacy only)
Active Ingredient: Ibuprofen 100mg
Dosage Form: Chewable tablet
New Zealand Sponsor: Haleon New Zealand ULC
Manufacturers: PF Consumer Healthcare Canada ULC, Montreal, Canada
   
Product: Advil Children 7-12 Years Pain & Fever Relief (General sale)
Active Ingredient: Ibuprofen 100mg
Dosage Form: Chewable tablet
New Zealand Sponsor: Haleon New Zealand ULC
Manufacturer: PF Consumer Healthcare Canada ULC, Montreal, Canada
   
Product: Fludrocortisone (Medicianz)
Active Ingredient: Fludrocortisone acetate 0.1mg
Dosage Form: Tablet
New Zealand Sponsor: Medsurge Pharma Limited
Manufacturer: Adamed Pharma SA, Pabianice, Poland
   
Product: Fludrocortisone (Medsurge)
Active Ingredient: Fludrocortisone acetate 0.1mg
Dosage Form: Tablet
New Zealand Sponsor: Medsurge Pharma Limited
Manufacturer: Adamed Pharma SA, Pabianice, Poland
   
Product: Keytruda
Active Ingredient: Pembrolizumab 25mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers: MSD International GmbH (Singapore Branch), Singapore City, Singapore
MSD International GmbH, t/a MSD Ireland (Carlow), Carlow, Ireland
   
Product: KISQALI
Active Ingredient: Ribociclib succinate 254.4mg equivalent to ribociclib 200mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Singapore Pharmaceutical Manufacturing Pte Limited, Singapore City, Singapore
Novartis Pharmaceutical Manufacturing LLC, Ljubljana, Slovenia
   
Product: Tagrisso
Active Ingredient: Osimertinib mesilate 47.7mg equivalent to osimertinib 40mg
Dosage Form: Film coated tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer: AstraZeneca AB, Sodertalje, Sweden
   
Product: Tagrisso
Active Ingredient: Osimertinib mesilate 95.4mg equivalent to osimertinib 80mg
Dosage Form: Film coated tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer: AstraZeneca AB, Sodertalje, Sweden
   
Product: Utrogestan
Active Ingredient: Progesterone 200mg
Dosage Form: Capsule
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturers: Olic (Thailand) Limited, Ayutthaya, Thailand
Cyndea Pharma S.L., Soria, Spain
NextPharma Ploermel, Ploermel, France


Dated this 27th day of June 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).